Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Ramiro Ribeiro

Chief Medical Officer at EyePoint Pharmaceuticals, Inc. (EYPT); Chief Medical Officer at EyePoint, Inc. (EYPT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $949K

Reported trades

Filed Stock Type Shares Price Value Since
Jul 2SEC EYPTEyePoint, Inc. Sell Plan 2,4372,438 held (−50%) $15.00 $37K -77.3%
Jul 2SEC EYPTEyePoint, Inc. Sell Plan 2,438 $15.02 $37K -77.4%
Apr 20SEC EYPTEyePoint, Inc. Sell Plan 2,437 $15.00 $37K -77.3%
Mar 5SEC EYPTEyePoint, Inc. Sell Plan 2,438 $17.87 $44K -81.0%
Feb 18SEC EYPTEyePoint, Inc. Sell Plan 2,437 $15.00 $37K -77.3%
Jan 7SEC EYPTEyePoint, Inc. Sell Plan 42,544 $17.10 $728K -80.1%
Nov 12SEC EYPTEyePoint Pharmaceuticals, Inc. Sell Plan 2,722 $11.61 $32K -70.7%
  • Sell

    Chief Medical Officer Ramiro Ribeiro sold $37K of EYPT at $15.00 — cuts the stake by 50%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Ramiro Ribeiro sold $37K of EYPT at $15.02 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Ramiro Ribeiro sold $37K of EYPT at $15.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Ramiro Ribeiro sold $44K of EYPT at $17.87 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Ramiro Ribeiro sold $37K of EYPT at $15.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Ramiro Ribeiro sold $728K of EYPT at $17.10 — pre-scheduled 10b5-1 plan sale.